SAN DIEGO, July 6, 2022 /PRNewswire/ Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, today announcedthe acquisition of DiscoveryBioMed, a contract research organization (CRO) focused on developing novel human bioassays utilizing cells from diseased and normal human tissues. Eurofins Discovery acquired DiscoveryBioMed for its expertise in leveraging primary and immortalized human diseased and normal cells to develop novel, customized bioassays supporting clients from HTS to lead optimization. DiscoveryBioMed achieves this through its focus on biologically relevant cellular models for the renal, skin, taste, ophthalmic, liver, respiratory, oncology, and other therapeutic areas. The addition of DiscoveryBioMed supports Eurofins Discovery's strategy to have the most complete, highest quality portfolio of drug discovery services and products, and further strengthens its ability to support tr
Eurofins Announces the Success of Its Tender Offers on Its Existing Hybrid Bonds streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Regulatory News: Eurofins Scientific (EUFI.PA, rated Baa3/positive by Moody's and BBB-/stable by Fitch rating, "Eurofins") (Paris:ERF), a global leader in bioanalytical testing, announces today:
Regulatory News: Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3/positive by Moody's and BBB/stable- by Fitch, "Eurofins"), a global leader in bioanalytical testing, announces that it has successfully